NCT04965896

Brief Summary

There is some evidence to suggest that the timing of a meal intake directly impacts postprandial insulin and glucose responses, with meals consumed later during the day being more metabolically detrimental that the same meals consumed during the day. This information is particularly pertinent to the 16% of people employed in shift-work professions in Australia who have little choice but to eat during the late evening and overnight. The purpose of this study is to compare two effect of different meals or snacks (control vs test meal) on blood glucose and insulin at night time in healthy adults. This study will enable to develop suitable meals to consume at night time that can reduce the higher glucose and insulin responses that are a consequence of eating late into the night.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Dec 2024

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 8, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 16, 2021

Completed
3.4 years until next milestone

Study Start

First participant enrolled

December 1, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2025

Completed
Last Updated

November 22, 2024

Status Verified

November 1, 2024

Enrollment Period

8 months

First QC Date

July 8, 2021

Last Update Submit

November 19, 2024

Conditions

Keywords

glucose tolerancemeal timinginsulinnutspostprandial

Outcome Measures

Primary Outcomes (2)

  • Postprandial plasma glucose area under the curve (iAUC)

    Difference in postprandial plasma glucose iAUC

    Three hour glucose iAUC will be calculated at nine time points (0, 15, 30, 45, 60, 90, 120, 150 and 180 mins) after beginning consumption of the test meal.

  • Postprandial plasma insulin iAUC

    Difference in postprandial plasma insulin iAUC

    Three hour glucose iAUC will be calculated at seven time points (0, 30, 60, 90, 120, 150 and 180 mins) after beginning consumption of the test meal.

Secondary Outcomes (3)

  • Postprandial glucose concentration

    Glucose concentration will be measured at nine time points (0, 15, 30, 45, 60, 90, 120, 150 and 180 mins) after beginning consumption of the test meal.

  • Postprandial insulin concentration

    Insulin concentration will be measured in finger prick blood samples at seven time points (0, 30, 60, 90, 120, 150 and 180 mins) after beginning consumption of the test meal.

  • Time to peak glucose

    Three hours

Study Arms (2)

Control meal

PLACEBO COMPARATOR

Participants will receive plain white rice (75g of available carbohydrate) alongside a snack with crackers and cheese. The meal is similar in energy and macronutrients to the test meal.

Other: Control meal

Nut meal

EXPERIMENTAL

Participants will receive plain white rice (75g of available carbohydrate) alongside a portion of 30g of nuts. The meal is similar in energy and macronutrients to the control meal.

Other: Nut meal

Interventions

Participants will receive plain white rice (75g of available carbohydrate) alongside a snack with crackers and cheese. The meal is similar in energy and macronutrients to the test meal.

Control meal

Participants will receive plain white rice (75g of available carbohydrate) alongside a portion of 30g of nuts. The meal is similar in energy and macronutrients to the control meal.

Nut meal

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • to 50 years of age
  • Waist circumference of \<94cm and \<80cm for Caucasian males and females, respectively
  • Waist circumference of \<90cm and \<80 cm for Asian males and females, respectively
  • Available to attend two testing sessions at the research facility

You may not qualify if:

  • Diagnosed with type 2 diabetes or taking anti-diabetic medication (oral hypoglycaemic agents)
  • Impaired fasting glucose (≥ 7 mmol/L)
  • Gastrointestinal conditions that may affect glycaemic response
  • Serious health conditions that may affect participation e.g. liver or thyroid dysfunction, recent major surgery
  • Women planning pregnancy, pregnant or lactating.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

HyperglycemiaInsulin Resistance

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesHyperinsulinism
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
CROSSOVER
Model Details: Participants will complete 2 study sessions at night, consuming plain white rice (corresponding to 75g of available carbohydrate) alongside each test meal (either the nuts or control meal) on two separate occasions. The order of scheduling of the sessions will be randomised.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

July 8, 2021

First Posted

July 16, 2021

Study Start

December 1, 2024

Primary Completion

July 30, 2025

Study Completion

October 30, 2025

Last Updated

November 22, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share